Lexicon Pharmaceuticals | LXRX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Abbott USD 175.87B 17.82B 2026-07
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 1.81B 199M 2026-07
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 27.84B 16.31B 2026-07
AstraZeneca USD 197.73B 92.26B 2026-07
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Illumina USD 31.55B 13.68B 2026-07
Insmed USD 14.85B 20.45B 2026-07
J&J USD 602.98B 8.38B 2026-07
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 287M 103M 2026-07
MannKind USD 757M 984M 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Novartis USD 264.25B 23.66B 2026-07
PTC Therapeutics USD 5.71B 68M 2026-07
Sarepta Therapeutics USD 2.28B 30M 2026-03
Thermo Fisher Scientific USD 218.23B 27.58B 2026-07
Ultragenyx Pharmaceutical USD 2.06B 2M 2026-07
United Therapeutics USD 25.19B 4.21B 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12